Different methods of enhancing the efficacy of topical tacrolimus in extra-facial vitiligo: A comparative study

J Cosmet Dermatol. 2021 Nov;20(11):3545-3551. doi: 10.1111/jocd.14024. Epub 2021 Mar 5.

Abstract

Background: Vitiligo is an acquired pigmentation disorder due to loss of melanocytes. Topical tacrolimus is effective in vitiligo treatment with minimal effect on extra-facial lesions.

Objective: To assess different methods of enhancing the absorption of topical tacrolimus in extra-facial vitiligo sites using microneedling and occlusion.

Methods: This study included 20 adult patients of both sexes with non-segmental vitiligo. Four extra-facial vitiligo lesions in each patient were randomly labeled A, B, C, and D and treated as follows: area A: tacrolimus ointment (0.03%) application twice/day, area B: microneedling once/week and tacrolimus ointment application directly after microneedling and twice/day the rest of the week, area C: microneedling once/week alone, and area D: tacrolimus ointment application twice/day under occlusion by polyethylene foil. The evaluation was done clinically by calculating the re-pigmentation percent after 6 months of treatment.

Results: Responders in area B were 45%, and 35% in area C, and 25% in both areas A and D. No statistically significant difference was detected regarding the re-pigmentation percent between the four areas (p > 0.05). No correlations were detected between re-pigmentation percent and patients' data.

Conclusion: Combination of microneedling and topical tacrolimus has an edge over monotherapy in vitiligo, and further studies are needed to verify such results.

Keywords: extra-facial vitiligo; microneedling; occlusion; topical tacrolimus.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Face
  • Female
  • Humans
  • Male
  • Pigmentation Disorders*
  • Tacrolimus
  • Treatment Outcome
  • Vitiligo* / drug therapy

Substances

  • Tacrolimus